Management of Chronic Subdural Hematoma: A Systematic Review and Component Network Meta-analysis of 455 Studies With 103 645 Cases.
Journal
Neurosurgery
ISSN: 1524-4040
Titre abrégé: Neurosurgery
Pays: United States
ID NLM: 7802914
Informations de publication
Date de publication:
01 12 2022
01 12 2022
Historique:
received:
18
04
2022
accepted:
14
07
2022
pubmed:
29
9
2022
medline:
19
11
2022
entrez:
28
9
2022
Statut:
ppublish
Résumé
Chronic subdural hematoma (CSDH) is a common neurosurgical condition with a high risk of recurrence after treatment. To assess and compare the risk of recurrence, morbidity, and mortality across various treatments for CSDH. A systematic review and meta-analysis was performed. PubMed/MEDLINE, EMBASE, SCOPUS, and Web of Science were searched from January 01, 2000, to July 07, 2021. The primary outcome was recurrence, and secondary outcomes were morbidity and mortality. Component network meta-analyses (CNMAs) were performed for surgical and medical treatments, assessing recurrence and morbidity. Incremental risk ratios (iRRs) with 95% CIs were estimated for each component. In total, 12 526 citations were identified, and 455 studies with 103 645 cases were included. Recurrence occurred in 11 491/93 525 (10.8%, 95% CI 10.2-11.5, 418 studies) cases after surgery. The use of a postoperative drain (iRR 0.53, 95% CI 0.44-0.63) and middle meningeal artery embolization (iRR 0.19, 95% CI 0.05-0.83) reduced recurrence in the surgical CNMA. In the pharmacological CNMA, corticosteroids (iRR 0.47, 95% CI 0.36-0.61) and surgical intervention (iRR 0.11, 95% CI 0.07-0.15) were associated with lower risk. Corticosteroids were associated with increased morbidity (iRR 1.34, 95% CI 1.05-1.70). The risk of morbidity was equivalent across surgical treatments. Recurrence after evacuation occurs in approximately 10% of cSDHs, and the various surgical interventions are approximately equivalent. Corticosteroids are associated with reduced recurrence but also increased morbidity. Drains reduce the risk of recurrence, but the position of drain (subdural vs subgaleal) did not influence recurrence. Middle meningeal artery embolization is a promising treatment warranting further evaluation in randomized trials.
Sections du résumé
BACKGROUND
Chronic subdural hematoma (CSDH) is a common neurosurgical condition with a high risk of recurrence after treatment.
OBJECTIVE
To assess and compare the risk of recurrence, morbidity, and mortality across various treatments for CSDH.
METHODS
A systematic review and meta-analysis was performed. PubMed/MEDLINE, EMBASE, SCOPUS, and Web of Science were searched from January 01, 2000, to July 07, 2021. The primary outcome was recurrence, and secondary outcomes were morbidity and mortality. Component network meta-analyses (CNMAs) were performed for surgical and medical treatments, assessing recurrence and morbidity. Incremental risk ratios (iRRs) with 95% CIs were estimated for each component.
RESULTS
In total, 12 526 citations were identified, and 455 studies with 103 645 cases were included. Recurrence occurred in 11 491/93 525 (10.8%, 95% CI 10.2-11.5, 418 studies) cases after surgery. The use of a postoperative drain (iRR 0.53, 95% CI 0.44-0.63) and middle meningeal artery embolization (iRR 0.19, 95% CI 0.05-0.83) reduced recurrence in the surgical CNMA. In the pharmacological CNMA, corticosteroids (iRR 0.47, 95% CI 0.36-0.61) and surgical intervention (iRR 0.11, 95% CI 0.07-0.15) were associated with lower risk. Corticosteroids were associated with increased morbidity (iRR 1.34, 95% CI 1.05-1.70). The risk of morbidity was equivalent across surgical treatments.
CONCLUSION
Recurrence after evacuation occurs in approximately 10% of cSDHs, and the various surgical interventions are approximately equivalent. Corticosteroids are associated with reduced recurrence but also increased morbidity. Drains reduce the risk of recurrence, but the position of drain (subdural vs subgaleal) did not influence recurrence. Middle meningeal artery embolization is a promising treatment warranting further evaluation in randomized trials.
Identifiants
pubmed: 36170165
doi: 10.1227/neu.0000000000002144
pii: 00006123-202212000-00004
doi:
Types de publication
Systematic Review
Meta-Analysis
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
842-855Informations de copyright
Copyright © Congress of Neurological Surgeons 2022. All rights reserved.
Références
Rauhala M, Helén P, Huhtala H, et al. Chronic subdural hematoma—incidence, complications, and financial impact. Acta Neurochir (Wien). 2020;162(9):2033-2043.
Rauhala M, Luoto TM, Huhtala H, et al. The incidence of chronic subdural hematomas from 1990 to 2015 in a defined Finnish population. J Neurosurg. 2019;132(4):1147-1157.
Stubbs DJ, Vivian ME, Davies BM, Ercole A, Burnstein R, Joannides AJ. Incidence of chronic subdural haematoma: a single-centre exploration of the effects of an ageing population with a review of the literature. Acta Neurochir (Wien). 2021;163(9):2629-2637.
Toi H, Kinoshita K, Hirai S, et al. Present epidemiology of chronic subdural hematoma in Japan: analysis of 63,358 cases recorded in a national administrative database. J Neurosurg. 2018;128(1):222-228.
Neifert SN, Chaman EK, Hardigan T, et al. Increases in subdural hematoma with an aging population-the future of American cerebrovascular disease. World Neurosurg. 2020;141:e166-e174.
Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ. Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflamm. 2017;14(1):108.
Pripp AH, Stanisic M. The correlation between pro- and anti-inflammatory cytokines in chronic subdural hematoma patients assessed with factor analysis. PLoS One. 2014;9(2):e90149.
Stanisic M, Lyngstadaas SP, Pripp AH, et al. Chemokines as markers of local inflammation and angiogenesis in patients with chronic subdural hematoma: a prospective study. Acta Neurochir (Wien). 2012;154(1):113-120.
Frati A, Salvati M, Mainiero F, et al. Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study. J Neurosurg. 2004;100(1):24-32.
Nakagawa I, Park HS, Kotsugi M, et al. Enhanced hematoma membrane on DynaCT images during middle meningeal artery embolization for persistently recurrent chronic subdural hematoma. World Neurosurg. 2019;126:e473-e479.
Nakaguchi H, Tanishima T, Yoshimasu N. Factors in the natural history of chronic subdural hematomas that influence their postoperative recurrence. J Neurosurg. 2001;95(2):256-262.
Baschera D, Tosic L, Westermann L, Oberle J, Alfieri A. Treatment standards for chronic subdural hematoma: results from a survey in Austrian, German, and Swiss neurosurgical units. World Neurosurg. 2018;116:e983-e995.
Cenic A, Bhandari M, Reddy K. Management of chronic subdural hematoma: a national survey and literature review. Can J Neurol Sci. 2005;32(4):501-506.
Brennan PM, Kolias AG, Joannides AJ, et al. The management and outcome for patients with chronic subdural hematoma: a prospective, multicenter, observational cohort study in the United Kingdom. J Neurosurg. 2017;127(4):732-739.
Edlmann E, Giorgi-Coll S, Hutchinson PJ, Carpenter KLH. Mechanisms of inflammation and the role of dexamethasone in treating chronic subdural haematoma. Brain Neurosci Adv. 2017;1:58.
Hutchinson PJ, Edlmann E, Bulters D, et al. Trial of dexamethasone for chronic subdural hematoma. N Engl J Med. 2020;383(27):2616-2627.
Ng S, Boetto J, Huguet H, et al. Corticosteroids as an adjuvant treatment to surgery in chronic subdural hematomas: a multi-center double-blind randomized placebo-controlled trial. J Neurotrauma. 2021;38(11):1484-1494.
Jiang R, Zhao S, Wang R, et al. Safety and efficacy of atorvastatin for chronic subdural hematoma in Chinese patients: a randomized clinical trial. JAMA Neurol. 2018;75(11):1338-1346.
Ironside N, Nguyen C, Do Q, et al. Middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta-analysis. J Neurointerv Surg. 2021;13(10):951-957.
Link TW, Boddu S, Paine SM, Kamel H, Knopman J. Middle meningeal artery embolization for chronic subdural hematoma: a series of 60 cases. Neurosurgery. 2019;85(6):801-807.
Almenawer SA, Farrokhyar F, Hong C, et al. Chronic subdural hematoma management: a systematic review and meta-analysis of 34,829 patients. Ann Surg. 2014;259(3):449-457.
Ou Y, Dong J, Wu L, et al. A comparative study of chronic subdural hematoma in three age ranges: below 40 years, 41-79 years, and 80 years and older. Clin Neurol Neurosurg. 2019;178:63-69.
Soleman J, Lutz K, Schaedelin S, et al. Subperiosteal vs subdural drain after burr-hole drainage of chronic subdural hematoma: a randomized clinical trial (cSDH-Drain-Trial). Neurosurgery. 2019;85(5):E825-E834.
Rauhala M, Helen P, Seppa K, et al. Long-term excess mortality after chronic subdural hematoma. Acta Neurochir (Wien). 2020;162(6):1467-1478.
Kolias AG, Chari A, Santarius T, Hutchinson PJ. Chronic subdural haematoma: modern management and emerging therapies. Nat Rev Neurol. 2014;10(10):570-578.
Santarius T, Kirkpatrick PJ, Ganesan D, et al. Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial. Lancet (Lond, Engl). 2009;374(9695):1067-1073.
Efthimiou O, Debray TPA, van Valkenhoef G, et al. GetReal in network meta-analysis: a review of the methodology. Res Synth Methods. 2016;7(3):236-263.
Rouse B, Chaimani A, Li T. Network meta-analysis: an introduction for clinicians. Intern Emerg Med. 2017;12(1):103-111.
Dias S, Caldwell DM. Network meta-Analysis explained. Arch Dis Child Fetal Neonatal Ed. 2019;104(1):F8-F12.
Riley RD, Jackson D, Salanti G, et al. Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples. BMJ. 2017;358:j3932.
Golub D, Hyde J, Dogra S, et al. Intraoperative MRI versus 5-ALA in high-grade glioma resection: a network meta-analysis. J Neurosurg. 2020;134(2):1-15.
Jain P, Tomlinson G, Snead C, Sander B, Widjaja E. Systematic review and network meta-analysis of resective surgery for mesial temporal lobe epilepsy. J Neurol Neurosurg Psychiatry. 2018;89(11):1138-1144.
Henry J, Amoo M, Taylor J, O’Brien DP. Complications of cranioplasty in relation to material: systematic review, network meta-analysis and meta-regression. Neurosurgery. 2021;89(3):383-394.
Wade RG, Burr NE, McCauley G, Bourke G, Efthimiou O. The comparative efficacy of chlorhexidine gluconate and povidone-iodine antiseptics for the prevention of infection in clean surgery: a systematic review and network meta-analysis. Ann Surg. 2021;274(6):e481-e488.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777-784.
Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366.
McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2020;12(1):55-61.
Chaimani A, Higgins JPT, Mavridis D, Spyridonos P, Salanti G. Graphical tools for network meta-analysis in STATA. PLoS One. 2013;8(10):76654.
Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22(4):153-160.
Rucker G, Krahn U, Konig J, Efthimiou O, Papakonstantinou T, Schwarzer G. netmeta: Network Meta-analysis Using Frequentist Methods; 2022. Accessed May 28, 2022. https://cran.r-project.org/web/packages/netmeta/index.html .
Viechtbauer W. Conducting meta-analyses in R with the metafor. J Stat Softw. 2010;36(3):1-48.
Rücker G. Network meta-analysis, electrical networks and graph theory. Res Synth Methods. 2012;3(4):312-324.
Cipriani A, Higgins JPT, Geddes JR, Salanti G. Conceptual and technical challenges in network meta-analysis. Ann Intern Med. 2013;159(2):130-137.
Chaimani A, Salanti G, Leucht S, Geddes JR, Cipriani A. Common pitfalls and mistakes in the set-up, analysis and interpretation of results in network meta-analysis: what clinicians should look for in a published article. Evid Based Ment Health. 2017;20(3):88-94.
Efthimiou O, Mavridis D, Debray TPA, et al. Combining randomized and non-randomized evidence in network meta-analysis. Stat Med. 2017;36(8):1210-1226.
Turner RM, Jackson D, Wei Y, Thompson SG, Higgins JPT. Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis. Stat Med. 2015;34(6):984-998.
Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010;29(7-8):932-944.
Higgins JPT, Jackson D, Barrett JK, Lu G, Ades AE, White IR. Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies. Res Synth Methods 2012;3(2):98-110.
Rücker G, Petropoulou M, Schwarzer G. Network meta-analysis of multicomponent interventions. Biom J. 2020;62(3):808-821.
Rücker G, Schmitz S, Schwarzer G. Component network meta-analysis compared to a matching method in a disconnected network: a case study. Biom J. 2021;63(2):447-461.
Ng S, Derraz I, Boetto J, et al. Middle meningeal artery embolization as an adjuvant treatment to surgery for symptomatic chronic subdural hematoma: a pilot study assessing hematoma volume resorption. J Neurointerv Surg. 2020;12(7):695-699.
Shotar E, Meyblum L, Premat K, et al. Middle meningeal artery embolization reduces the post-operative recurrence rate of at-risk chronic subdural hematoma. J Neurointerv Surg. 2020;12(12):1209-1213.
Onyinzo C, Berlis A, Abel M, Kudernatsch M, Maurer CJ. Efficacy and mid-term outcome of middle meningeal artery embolization with or without Burr Hole evacuation for chronic subdural hematoma compared with Burr Hole evacuation alone. J Neurointerv Surg. 2022;14(3):297-300.
Ban SP, Hwang G, Byoun HS, et al. Middle meningeal artery embolization for chronic subdural hematoma. Radiology. 2018;286(3):992-999.
Rücker G, Schwarzer G. Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Med Res Methodol. 2015;15(1):58.
Nikolakopoulou A, Higgins JPT, Papakonstantinou T, et al. CINeMA: an approach for assessing confidence in the results of a network meta-analysis. PLoS Med. 2020;17(4):e1003082.
csdh-cnma. 2022. http://www.github.com/jckhry/csdh-cnma .
Management of Chronic Subdural Hematoma: A Systematic Review & Component Network Meta-analysis Of 455 Studies With 103,645 Cases. Zenodo. DOI: 10.5281/zenodo.6594965.
Management of Chronic Subdural Hematoma: A Systematic Review & Component Network Meta-analysis Of 455 Studies With 103,645 Cases. Open Science Foundation. DOI: 10.17605/OSF.IO/QRBE4.
Joyce E, Bounajem MT, Scoville J, et al. Middle meningeal artery embolization treatment of nonacute subdural hematomas in the elderly: a multiinstitutional experience of 151 cases. Neurosurg Focus. 2020;49(4):E5.
Amoo M, O’Cearbhaill RM, McHugh P, et al. Derivation of a clinical score for prediction of recurrence following evacuation of chronic subdural hematoma: a retrospective cohort study at a National Referral Centre. World Neurosurg. 2021;154:e743-e753.
Hoffman H, Jalal MS, Bunch KM, Chin LS. Management of chronic subdural hematoma with the subdural evacuating port system: systematic review and meta-analysis. J Clin Neurosci. 2021;86:154-163.
Duerinck J, Van Der Veken J, Schuind S, et al. Randomized trial comparing Burr Hole craniostomy, minicraniotomy, and twist drill craniostomy for treatment of chronic subdural hematoma. Neurosurgery. 2022;91(2):304-311.
Jensen TSR, Andersen-Ranberg N, Poulsen FR, Bergholt B, Hundsholt T, Fugleholm K. The Danish Chronic Subdural Hematoma Study—comparison of hematoma age to the radiological appearance at time of diagnosis. Acta Neurochir (Wien). 2020;162(9):2007-2013.
Miah IP, Tank Y, Rosendaal FR, et al. Radiological prognostic factors of chronic subdural hematoma recurrence: a systematic review and meta-analysis. Neuroradiology. 2021;63(1):27-40.
Yadav YR, Ratre S, Parihar V, Bajaj J, Sinha M, Kumar A. Endoscopic management of chronic subdural hematoma. J Neurol Surg A Cent Eur Neurosurg. 2020;81(4):330-341.
Sale D. Single versus double Burr Hole for drainage of chronic subdural hematoma: randomized controlled study. World Neurosurg. 2021;146:e565-e567.
Guilfoyle MR, Hutchinson PJA, Santarius T. Improved long-term survival with subdural drains following evacuation of chronic subdural haematoma. Acta Neurochir (Wien). 2017;159(5):903-905.
Link TW, Schwarz JT, Paine SM, Kamel H, Knopman J. Middle meningeal artery embolization for recurrent chronic subdural hematoma: a case series. World Neurosurg. 2018;118:e570-e574.
Schwarz J, Carnevale JA, Goldberg JL, Ramos AD, Link TW, Knopman J. Perioperative prophylactic middle meningeal artery embolization for chronic subdural hematoma: a series of 44 cases. J Neurosurg. Published online ahead of print May 21, 2021. DOI: 10.3171/2020.10.JNS202856.
doi: 10.3171/2020.10.JNS202856
Carpenter A, Rock M, Dowlati E, et al. Middle meningeal artery embolization with subdural evacuating port system for primary management of chronic subdural hematomas. Neurosurg Rev. 2021;45(1):439-449.
Enriquez-Marulanda A, Gomez-Paz S, Salem MM, et al. Middle meningeal artery embolization versus conventional treatment of chronic subdural hematomas. Neurosurgery. 2021;89(3):486-495.
Search of: middle meningeal artery|chronic subdural hematoma—List Results—ClinicalTrials.gov. Accessed August 29, 2021. https://clinicaltrials.gov/ct2/results?cond=chronic+subdural+hematoma&term=middle+meningeal+artery&cntry=&state=&city=&dist=
Haldrup M, Ketharanathan B, Debrabant B, et al. Embolization of the middle meningeal artery in patients with chronic subdural hematoma—a systematic review and meta-analysis. Acta Neurochir (Wien). 2020;162(4):777-784.
Dian J, Linton J, Shankar JJ. Risk of recurrence of subdural hematoma after EMMA vs surgical drainage—systematic review and meta-analysis. Interv Neuroradiol. 2021;27(4):577-583.
Miranda LB, Braxton E, Hobbs J, Quigley MR. Chronic subdural hematoma in the elderly: not a benign disease. J Neurosurg. 2011;114(1):72-76.